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Introduction
Major depressive disorder (MDD) is an incapacitating mental disorder characterized by episodes of at least 2 weeks of apparent changes in affection, cognition, and neurovegetative functions. 1 Patients with MDD present a lower quality of life and higher prevalence of medical conditions. The global prevalence of MDD is approximately 5%. According to the World Health Organization, MDD is estimated to become the second most disabling condition by 2020. 2 Several neurobiological models have been proposed to explain the pathogenesis of MDD. Because MDD is primarily related to lower affection and humor, many authors have studied and emphasized the role of dysfunctional cortico-limbic networks in MDD. 3 Postmortem and animal model studies have reported lower hippocampal volume (HcV) in participants with depressive disorders. The hippocampus is involved in episodic and declarative memory, as well as in learning, areas that often present deficits in patients with depression. 4 The suggestion that HcV is lower because of depression has been influential in guiding neuroimaging studies on the analysis of the hippocampus. 5 Many neuroimaging studies using magnetic resonance imaging (MRI) have examined morphometric changes in patients with MDD, but the results are not conclusive.
Some studies have reported bilateral, 6 unilateral right, 7 or unilateral left hippocampal hypotrophy in these patients compared with healthy participants, 8, 9 whereas others have reported no changes. 10, 11 Furthermore, some systematic reviews and meta-analyses have examined studies on HcV in the first depressive episode or in specific groups, such as the elderly (aged ≥ 60 years) with depression. 7, [12] [13] [14] However, to date, no reviews have systematically examined the macro influence of depression on HcV.
This study aims to examine whether patients with MDD present hippocampal atrophy compared with nondepressive participants. We considered HcV reduction as the primary outcome. For each data criterion, a data extraction table was pilot-tested on five randomly-selected studies and adjusted accordingly. Two independent reviewers assessed the following data from the patient and control samples: number of participants, HcV means and standard deviations, and mean disease duration.
Methods
A third author double-checked the extracted data.
Disagreements were resolved by consensus between the authors; if no consensus could be reached, a third author made a decision. All volumes were converted to mm 3 before being entered into the meta-analysis.
To certify the quality and validity of the eligible studies, pairs of reviewers working independently assessed each study using the Strengthening The
Reporting of Observational Studies in Epidemiology
(STROBE) checklist. 16 Calculations were performed using the STATA software version 13.0 SE. The meta-analyses were performed using a random effects model weighting the studies by the inverse variance and calculating the Hedges' g effect size. The random effects model using the DerSimonian-Laird method was selected over the fixed effects approach because previous analyses have indicated considerable between-study heterogeneity.
To assess for between-study heterogeneity, the Cochran Q test was performed and I² statistic was recorded and further analyzed by meta-regression.
Begg's and Egger's tests were used to determine publication bias.
Results
Twenty-nine studies comprising 1327 patients and 1004 healthy participants fulfilled both inclusion and exclusion criteria and were included in this metaanalysis. [6] [7] [8] [9] [11] [12] [13] [14] One study that found lower left HcV was excluded because volume measurements were unavailable. 38 A report by Andreescu et al. 39 was also excluded because only global HcV measurements were available. Pantel et al. 40 reported a study in German that was excluded from the analysis because of language limitations.
All studies selected for this review were crosssectional studies published in English, except one cohort study. 30 The main inclusion criteria entailed adults (≥18
years). The Hamilton Depression Scale was the main
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Studies included in qualitative synthesis and meta-analysis (n = 29) two of these measurements markedly deviated from the mean. 9, 14 Sample characteristics of the included studies are presented in Table 1 . Some of the studies included patients with recurrent depression, 6 first-episode depression, 12, 17, 26 and late-onset depression. 7, 13, 21 Eight studies evaluated illness duration, which varied from 7
to 57 months. 6, 12, 18, 25, 27, 28, 33, 35 Begg's and Egger's tests were performed and showed no evident signs of publication bias (Figure 4) .
The meta-analysis was repeated, omitting one study at a time, to ensure that the result was not skewed by a single study. This analysis did not change the random-effects estimate, and the results continued to be statistically significant.
Because the studies had significant heterogeneity, the data were analyzed using meta-regression. We assumed that differences in age, sex, duration of illness, and year of publication could explain some of the variation. These variables were analyzed separately and together, but were not significantly correlated with the random-effects estimate in either the right or left hippocampus.
Discussion
The studies included in the analysis yielded highly heterogeneous results. Notably, this heterogeneity was expected because there were marked differences among the patient groups with respect to age and sex distribution, type of MDD (e.g., first episode, dysthymia, refractory, late onset), illness duration, age at the first episode, and factors related to treatment. Moreover, an increase in HcV variation was expected considering various protocols for the scanning and delineation of hippocampal structures.
However, a meta-analysis plays an important role in the analysis of scientific evidence because these possible confounding factors are diluted or neutralize It is established that HcV losses are expected as a natural process of aging 41 ; however, Sheline et al. 42 demonstrated that illness duration, not age, predicted hippocampal loss in women with recurrent MDD.
Only eight studies included in our analysis presented information about depression duration. However, in the meta-regression, neither illness duration nor age were significantly correlated with the random-effects estimate.
Seven studies failed to find significant HcV differences in patients with depression compared with healthy participants. 11, 18, 19, 28, 29, 32, 33 Six studies demonstrated significant reduction only in the right hippocampus. 7, 20, 21, 30, 31, 35 Six other studies showed similar findings in the lower left hippocampus. 8, 9, 12, 13, 36, 37 Bilateral hippocampal atrophy was reported in 10 studies. 6, 14, [22] [23] [24] [25] [26] [27] 34 MacQueen et al. 26 According to the results of Vakili et al., 32 a smaller volume of the right hippocampus was associated with poor responses to antidepressants. This result is incipient, as investigating this association was not the primary objective of the study. However, if confirmed, that finding would be clinically interesting as a potential predictor of treatment response.
The pathophysiological pathways that explain HcV reduction in MDD remain unclear. Some authors theorize that HcV reduction is associated with disturbed hypothalamic pituitary adrenal axis function and adrenal hypersecretion of glucocorticoids, particularly cortisol. According to this hypothesis, cortisol leads to neural atrophy and the inhibition of neurogenesis in the hippocampus. 43 Another important supporting mechanism is the glutamate N-methyl-D-aspartate (NMDA) channel present in inhibitory neurons that comprise this pathway. Subiculum neurons make a synapse with a hypothalamic neuron, inhibiting it through NMDA receptors. The hypothalamic neuron modulates the corticotropic cell, stimulating it through gamma-aminobutyric acid (GAMA) liberation, which culminates in the production and release of the adrenocorticotropic hormone (ACTH). Serum cortisol concentration increases as a product of ACTH, released from the adrenal gland. [44] [45] [46] It is important to address the potential protective properties of selective serotonin reuptake inhibitors 
Study limitations
In principle, cross-sectional studies such as those included in the present analysis do not allow conclusions about causality to be drawn.
Further, socioeconomic and lifestyle characteristics from specific population groups can act as confounders.
For example, the habit of regular exercise training is a protective factor against hippocampal atrophy and may be responsible for hippocampus hypertrophy in healthy participants. 48 Other factors can also act as confounders, such as the comorbidity of MDD and anxiety disorders, 49 which was not assessed in any of the studies. 
